PacBio gets $50M investment from Gen-Probe

Pacific Biosciences--a company that's never had any trouble raising money--has received a $50 million investment from molecular diagnostics firm Gen-Probe. The funding is part of a larger Series F private round of financing. The two companies will explore development of a clinical diagnostics systems using PacBio's Single Molecule Real Time (SMRT) platform and Gen-Probe's expertise in diagnostics. Report

Suggested Articles

Spinal Elements, maker of a wide range of implants and products for minimally invasive spine procedures, has filed a $100 million IPO.

United Airlines will begin providing COVID-19 screening tests for passengers, allowing those who test negative to skip local quarantine requirements.

Babson Diagnostics has closed its series A funding round with a total of $13.7 million and named a new CEO.